Recursion Pharmaceuticals, Inc. financial data

Symbol
RXRX on Nasdaq
Location
Salt Lake City, UT
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 5, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 401 % -18.4%
Debt-to-equity 38.7 % +3.04%
Return On Equity -72.7 % +4.99%
Return On Assets -52.5 % +5.77%
Operating Margin -1.66K % -174%

Shares

Label TTM Value / Value Unit Change %
Common Stock, Shares, Outstanding 492M shares +71.9%
Entity Public Float 1.51B USD +62.1%
Common Stock, Value, Issued 5K USD +66.7%
Weighted Average Number of Shares Outstanding, Basic 447M shares +58.2%
Weighted Average Number of Shares Outstanding, Diluted 447M shares +58.2%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 43.7M USD -33%
Research and Development Expense 478M USD +67.3%
General and Administrative Expense 220M USD +67.4%
Costs and Expenses 767M USD +67%
Operating Income (Loss) -724M USD -83.6%
Nonoperating Income (Expense) 7.87M USD -29.8%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -716M USD -86.9%
Income Tax Expense (Benefit) -147K USD +97.2%
Net Income (Loss) Attributable to Parent -716M USD -89.4%
Earnings Per Share, Basic -1 USD/shares -17.3%
Earnings Per Share, Diluted -1 USD/shares -17.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 660M USD +54.3%
Other Assets, Current 29.2M USD -31.6%
Assets, Current 714M USD +50.6%
Deferred Income Tax Assets, Net 957K USD
Property, Plant and Equipment, Net 112M USD +32.3%
Operating Lease, Right-of-Use Asset 47.8M USD -0.15%
Intangible Assets, Net (Excluding Goodwill) 322M USD +845%
Goodwill 162M USD +211%
Other Assets, Noncurrent 14.7M USD +3973%
Assets 1.4B USD +92.6%
Accounts Payable, Current 13.9M USD +517%
Employee-related Liabilities, Current 24.1M USD +22.3%
Accrued Liabilities, Current 53.1M USD +30.8%
Contract with Customer, Liability, Current 47.4M USD -4.47%
Liabilities, Current 155M USD +42.4%
Long-term Debt and Lease Obligation 11.9M USD -42%
Contract with Customer, Liability, Noncurrent 111M USD +608%
Deferred Income Tax Liabilities, Net 23.3M USD +13776%
Operating Lease, Liability, Noncurrent 50M USD -6.77%
Other Liabilities, Noncurrent 1.03M USD -65.7%
Liabilities 353M USD +74.6%
Accumulated Other Comprehensive Income (Loss), Net of Tax 34.1M USD
Retained Earnings (Accumulated Deficit) -1.97B USD -57.1%
Stockholders' Equity Attributable to Parent 1.05B USD +99.6%
Liabilities and Equity 1.4B USD +92.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -132M USD -29%
Net Cash Provided by (Used in) Financing Activities 40.5M USD +192%
Net Cash Provided by (Used in) Investing Activities -7.27M USD -9.27%
Common Stock, Shares Authorized 2B shares 0%
Common Stock, Shares, Issued 492M shares +71.9%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -93.9M USD +1.48%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 667M USD +53.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 13K USD -7.14%
Deferred Tax Assets, Valuation Allowance 466M USD +53%
Deferred Tax Assets, Gross 541M USD +69.1%
Operating Lease, Liability 81M USD +63.6%
Depreciation 18.3M USD +15.1%
Payments to Acquire Property, Plant, and Equipment 1.83M USD -72.5%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -681M USD -80.4%
Lessee, Operating Lease, Liability, to be Paid 101M USD +52.9%
Property, Plant and Equipment, Gross 204M USD +55.1%
Operating Lease, Liability, Current 11.5M USD +40%
Lessee, Operating Lease, Liability, to be Paid, Year Two 20.5M USD +96.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 19.4M USD +92.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 20.1M USD +21.1%
Lessee, Operating Lease, Liability, to be Paid, Year Three 20.8M USD +97.7%
Deferred Tax Assets, Operating Loss Carryforwards 274M USD +133%
Unrecognized Tax Benefits 6.75M USD +24.6%
Lessee, Operating Lease, Liability, to be Paid, Year Four 16.8M USD +55.9%
Operating Lease, Payments 5.27M USD +33.1%
Additional Paid in Capital 2.98B USD +67.7%
Amortization of Intangible Assets 44.8M USD +204%
Depreciation, Depletion and Amortization 19.3M USD +162%
Deferred Tax Assets, Net of Valuation Allowance 75.2M USD +383%
Share-based Payment Arrangement, Expense 117M USD +79.9%
Interest Expense 98K USD +63.3%